Sound Science
Respiragene™ is a gene-based test developed specifically for the United States market, founded on well-designed and validated clinical studies and endorsed by peer scientific review.
GOTO 
Published Research Events
Lung cancer susceptibility score and SNP panel
Young Robert P. et al. Functional variants of anti-oxidant genes in smokers with COPD and in those with normal lung function. Thorax 2006; 30: 1-7.
Young RP, Hopkins RJ, Hay BJ, et al. Lung cancer gene associated with COPD: triple whammy or possible confounding effect?. Eur Respir J 2008; 32: 1158-1164.
Young RP, Hopkins RJ, Eaton TE. Forced Expiratory Volume in one second: not just a lung function test but a marker of premature death from all causes. Eur Respir J 2007; 30(4): 616-622.
Possible therapeutic interventions in high risk smokers
Young RP, Hopkins RJ, Eaton TE. Potential benefits of statins on morbidity and mortality in chronic obstructive pulmonary disease: a review of the evidence. Postgraduate Medical Journal 2009
Young RP, Hopkins RJ, Smith M, Hogarth, DK. Smoking cessation: the potential role of risk assessment tools as motivational triggers. Postgraduate Medical Journal 2010; 86:26-33.
General Articles
Young RP, Hopkins RJ, Hay BA, Epton MJ, Mills GD, et al. A gene-based risk score for lung cancer susceptibility in smokers and ex-smokers. Postgraduate Medical Journal 2009
Young, RP, R Hopkins and TE Eaton Pharmacological actions of statins: potential utility in COPD. European Respiratory Review 2009;18: 222-232.
Young, Robert P. and Raewyn J. Hopkins. Statins Use and Pneumonia. Chest May 2010 137:1249.